1  frequency and severity of pharyngocutaneous fistula formation.

2 e be implicated in ulceration, fibrosis, and fistula formation.

3 initially because of the possibility of milk fistula formation.

4 d increased risk of postoperative pancreatic fistula formation.

5 actable enterocolitis, perianal disease, and fistula formation.

6 ng distal pancreatectomy reduces the rate of fistula formation.

7 te complications included five patients with fistula formation (11.6%) and four with ulceration/tissu

8 rted outcomes and clinical outcomes, such as fistula formation and infection, were inconsistently rep

9 t in delayed wound healing, wound breakdown, fistula formation, and compromised tissue reconstruction

10 gies that lead to increased percentage of AV fistula formation are the goal for rapid improvement in

11  intra-abdominal abscess and enterocutaneous fistula formation, have been well documented following p

12      Age and Veau Class were associated with fistula formation in a univariate analysis.

13               A primary barrier to native AV fistula formation is lack of timely referral.

14 nce of a fluid collection (n = 2), cutaneous fistula formation (n = 2), or technical failure, persist

15 pancreatic duct stents decreases the rate of fistula formation nor does placement of a drain at the t

16                    Strategies to increase AV fistula formation require early referral to nephrology a

17                                     Observed fistula formation/tissue necrosis may be bevacizumab rel